Get the Stockscreener App
3.55
0.00%
0.00
Nephros Inc stock is traded at $3.55, with a volume of 671.
It is up +0.00% in the last 24 hours and up +3.80% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$3.55
Open:
$3.6899
24h Volume:
671
Relative Volume:
0.03
Market Cap:
$40.06M
Revenue:
$19.12M
Net Income/Loss:
$776.00K
P/E Ratio:
50.28
EPS:
0.0706
Net Cash Flow:
$-348.00K
1W Performance:
-0.56%
1M Performance:
+3.80%
6M Performance:
-31.20%
1Y Performance:
-12.99%
1-Day Range:
$3.6899
$3.6899
1-Week Range:
$3.29
$3.7152
52-Week Range:
$2.6629
$6.42
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.49 | 2.67B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.00 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.30 | 349.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.97 | 361.32M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.45 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Inc. (NEPH) Edges Higher Amid Steady Trading — Key Levels in FocusUndervalued Stocks - dars.gov.et
Nephros, Inc.(NasdaqCM: NEPH) added to Russell 3000E Index - marketscreener.com
Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Nephros | 4: Statement of changes in beneficial ownership of securities-Officer Banks Robert R. Jr. - Moomoo
Nephros Bets on Services Over Sales: A Deeper Dive Into its 'Beyond Filtration' Play - BriefGlance
Nephros to Host Virtual Investor Event: 'Beyond Filtration: The Nephros Model in Action” - The Manila Times
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action” - Caledonian Record
Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why Is Nephros Drawing Attention In The Water Filtration Industry? - Kalkine Media
Nephros Inc (NEPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nephros Inc (NEPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nephros Inc (NEPH) Institutional Confidence - TradingKey
Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nephros highlights filtration technology for microplastics removal - Investing.com
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water - The Globe and Mail
NEPH Q1 2026 Earnings: EPS Falls Just Short of Expectations, Stock Declines 6.3%Earnings Preview - newsline.com
Nephros posts updated 2026 corporate presentation on website - TradingView
Nephros Inc. (NEPH) Holds Steady Near Support After Modest GainNAAIM Leverage - newsline.com
Nephros (NEPH) director awarded 3,574 shares and holds options expiring 2034–2035 - Stock Titan
Nephros (NASDAQ: NEPH) posts updated 2026 corporate presentation online - Stock Titan
NEPH Q1 2026 Earnings: EPS Slightly Misses Estimates, Stock DeclinesSpecial Dividend Alert - newsline.com
Nephros Q1 2026 Earnings: EPS Slightly Misses Estimate, Stock Dips 4.7%Share Dilution Risk - newsline.com
Nephros Slides 4.74% as Support Floor Tested (NEPH)Inside Day Breakout - newsline.com
NEPH Q1 2026 Earnings: EPS Just Below Consensus, Revenue UnreportedWeak Earnings Momentum - dars.gov.et
Nephros Inc. (NEPH) Edges Higher Amid Positive MomentumVolume Spike Alerts - thelegaladvocate.com
(05/26/26) NEPH: A Turnaround Play in the Water Filtration Business - moneyshow.com
NEPH Q1 2026 Earnings: Narrow EPS Miss Triggers Modest SelloffGuidance Accuracy Score - The Legal Advocate
NEPH Q1 2026 Earnings: Narrow EPS Miss Amid Operational DevelopmentsGross Profit Margin - Newser
Nephros, Inc. (NASDAQ:NEPH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00 - 富途牛牛
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
US$7.00That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results - Yahoo Finance
Nephros Earnings Call Balances Growth And Margin Pain - The Globe and Mail
Nephros, Inc. (NASDAQ:NEPH) Q1 2026 Earnings Call Transcript - Insider Monkey
Nephros (NEPH) Q1 2026 Earnings Transcript - AOL.com
Nephros expects tariff relief from 10% rate to support margins later in 2026 - MSN
Nephros, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Nephros : Q1 2026 Conference Call Replay - marketscreener.com
Earnings call transcript: Nephros Q1 2026 revenue beats forecast, stock rises - Investing.com Nigeria
Earnings call transcript: Nephros Q1 2026 revenue beats forecast, stock rises By Investing.com - Investing.com South Africa
Nephros Q1 gross margin falls on higher product costs from U.S. tariffs - TradingView
Nephros reports Q1 revenue $5.2M, net income $0.14M and adjusted EBITDA $0.206M - TradingView
[8-K] NEPHROS INC Reports Material Event - Stock Titan
Tariffs added $200,000 in costs as Nephros logged its first $5M quarter - Stock Titan
Press Release: Nephros Announces Financial Results for Quarter Ended March 31, 2026 - Moomoo
Nephros (NASDAQ: NEPH) posts Q1 2026 profit but faces margin pressure - Stock Titan
Nephros Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
NEPH Stock Price, Quote & Chart | NEPHROS INC (NASDAQ:NEPH) - ChartMill
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nephros Inc Stock (NEPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krandel Judy | Chief Financial Officer |
Mar 23 '26 |
Option Exercise |
1.71 |
68,861 |
117,752 |
68,861 |
3.48%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):